Anti-Epileptic Drugs: Global Markets to 2022

Report Code: PHM197A

Publish Date: Apr 2018

Publisher: BCC Publishing

Category: Pharmaceuticals

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global anti-epileptic drugs market totaled $8.4 billion in 2017 and is estimated to reach $9.5 billion by 2022, growing at a compound annual growth rate (CAGR) of 2.7% for the period of 2017-2022.

Report Includes

  • 94 data tables
  • Country specific data and analysis for China, India, Japan, Australia, United Kingdom, Germany, France, Italy, Spain, Russia, USA, and Brazil
  • Identification of segments with high growth potential and their future applications
  • Explanation of major drivers and regional dynamics of the market and current trends within the industry
  • Detailed profiles of major vendors in the market, including Eisai Co.Ltd., Glaxosmithkline Plc, Pfizer Inc., Sanofi S.A., UCB S.A.

Report Scope

This research report categorizes the anti-epileptic drugs market by type. Product type include first generation, second generation and third generation.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Analyst Credentials

BCC Research analysts craft reference reports with a unique end noted referencing methodology, which allows users to cross reference and trace market numbers back to their source. These individuals are experts in secondary research and primary forecasting - compiling and layering existing data with their original research and analysis. The team has decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Anti-Epileptic Drugs: Global Markets to 2022161Free
Chapter- 1: Introduction5Free
Chapter- 2: Summary and Highlights2Free
Chapter- 3: Anti-Epileptic Drugs Market Characteristics2Free
Chapter- 4: Anti-Epileptic Drugs Market Size and Growth5Free
Chapter- 5: Anti-Epileptic Drugs Market Trends and Strategies2Free
Chapter- 6: PESTLE Analysis3Free
Chapter- 7: Anti-Epileptic Drugs Market Segmentation4Free
Chapter- 8: Anti-Epileptic Drugs Market Regional and Country Analysis9Free
Chapter- 9: Global Anti-Epileptic Drugs Market Comparison with Macro Economic Factors1Free
Chapter- 10: Asia-Pacific Anti-Epileptic Drugs Market9Free
Chapter- 11: Asia-Pacific Anti-Epileptic Drugs Market: Country Analysis24Free
Chapter- 12: Western Europe Anti-Epileptic Drugs Market8Free
Chapter- 13: Western Europe Anti-Epileptic Drugs Market: Country Analysis23Free
Chapter- 14: Eastern Europe Anti-Epileptic Drugs Market7Free
Chapter- 15: Eastern Europe Anti-Epileptic Drugs Market: Country Analysis4Free
Chapter- 16: North America Anti-Epileptic Drugs Market7Free
Chapter- 17: North America Anti-Epileptic Drugs Market: Country Analysis4Free
Chapter- 18: South America Anti-Epileptic Drugs Market7Free
Chapter- 19: South America Anti-Epileptic Drugs Market: Country Analysis4Free
Chapter- 20: Middle East Anti-Epileptic Drugs Market7Free
Chapter- 21: Africa Anti-Epileptic Drugs Market7Free
Chapter- 22: Anti-Epileptic Drugs Market Customer Information1Free
Chapter- 23: Anti-Epileptic Drugs Market Competitive Landscape11Free
Chapter- 24: Key Mergers and Acquisitions in the Anti-Epileptic Drugs Market1Free
Chapter- 25: Appendix3Free

Related Reports

Global Markets for Generic Drugs

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM009K

The global market for generic drugs is expected to grow from $435.3 billion in 2023 and projected to reach $655.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.5% from 2023 to 2028.

Non-opioid Pain Treatment: Global Markets to 2024

Published - Jan 2020 | Publisher - BCC Publishing | Code - HLC206B

The global market for non-opioid pain treatments should grow from $13.8 billion in 2019 to $31.8 billion by 2024 at a compound annual growth rate (CAGR) of 18.3% for the period of 2019-2024.

Neuroprotective Agents: Therapeutic Applications and Global Markets

Published - Jul 2018 | Publisher - Ufuk Ezer | Code - PHM188A

The global market for neuroprotective agents will grow from $54.4 billion in 2017 to $75.8 billion by 2022 with a compound annual growth rate (CAGR) of 6.8% for the period of 2017-2022.

Breakthrough Therapies: Market Dynamics and Investment Opportunities

Published - Jan 2017 | Publisher - Dr. Cheryl Lee Barton | Code - PHM176A

The global market for breakthrough therapy designation drugs should reach $99.2 billion by 2022 from $48.8 billion in 2017 at a compound annual growth rate (CAGR) of 15.2%, from 2017 to 2022.

Recent Reports

Global Oncology Pharmaceuticals Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - PHM256B

The global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.

Excipients in Pharmaceuticals: Global Markets to 2029

Published - Sep 2024 | Publisher - Gundreddy Gopinadh | Code - PHM010M

The global market for pharmaceutical excipients was valued at $9.2 billion in 2023. It is expected to grow from $9.7 billion in 2024 to $12.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.1% from 2024 to 2029.

Antibody-Drug Conjugates: Technologies and Global Markets

Published - Sep 2024 | Publisher - BCC Publishing | Code - PHM161C

The global market for antibody-drug conjugates is estimated to increase from $10.8 billion in 2023 to reach $47.0 billion by 2029, at a compound annual growth rate (CAGR) of 28.4% from 2024 through 2029.

Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging

Published - Aug 2024 | Publisher - BCC Publishing | Code - PHM043J

The global market for contract pharmaceutical manufacturing, research and packaging is estimated to increase from $212.2 billion in 2023 to reach $310.2 billion by 2029, at a compound annual growth rate (CAGR) of 6.7% from 2024 through 2029.

Global Markets for Drug-Device Combinations

Published - Jul 2024 | Publisher - BCC Publishing | Code - PHM045F

The global market for drug-device combinations is expected to grow from $129.4 billion in 2024 and is projected to reach $199.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.1% during the forecast period of 2024 to 2029.

Top Trending Reports

Global Artificial Intelligence (AI) Market: Investments vs Potential

Published - Aug 2024 | Publisher - BCC Publishing | Code - IFT189C

The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.

Artificial Intelligence (AI) in Life Sciences Market

Published - Aug 2024 | Publisher - BCC Publishing | Code - BIO255A

The global market for artificial intelligence (AI) in life sciences products was valued at $8.0 billion in 2023. The market is estimated to grow from $9.8 billion in 2024 to $33.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.9% from 2024 to 2029.

Drug Discovery Technologies

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO020H

The global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 and is projected to reach $197.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.0% during the forecast period of 2024 to 2029.

Synthetic Biology: Global Markets

Published - Aug 2024 | Publisher - BCC Publishing | Code - BIO066H

The global market for synthetic biology products was valued at $15.4 billion in 2023. The market is projected to grow from $19.3 billion in 2024 to $61.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 26.1% from 2024 through 2029.

Gene Editing Therapeutics Market

Published - Aug 2024 | Publisher - BCC Publishing | Code - BIO259A

The report provides an overview of current and future market potential of gene editing therapeutics and provides a detailed analysis of the drivers, restraints and opportunities in this market. It also include company profiles of key players, featuring detailed information regarding each company’s business segments, financials, product portfolios and recent developments.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Anti-Epileptic Drugs: Global Markets to 2022
Customize Report